Product Program year 2020 Source: CMS Open Payments

CD cobas Analyzer Series

Device Centralized Diagnostics

Open in the dashboard

General payments

$153,352

107 payments

Research payments

$468,430

4 payments

Through program year 2020, $153,352 in general payments and $468,430 in research payments were reported against CD cobas Analyzer Series (Centralized Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $32,428 30
2020 Research $111,912 3
2019 General $120,925 77
2019 Research $356,518 1

Breakdown

Who paid General payments · program years 2019–2020
  1. Roche Diagnostics Corporation $115,748 74 payments
  2. Roche Diagnostics Operations, Inc. $37,605 33 payments
Top recipients General payments · program year 2020
  1. Timothy Peklo Family Medicine · Greensburg, IN $18,000 56% · 12 payments
  2. Karin Molander Emergency Medicine · Burlingame, CA $4,345 13% · 2 payments
  3. Christopher Baugh Emergency Medicine · Boston, MA $4,000 12% · 1 payment
  4. Joern Hendrik Weitkamp Neonatal-Perinatal Medicine · Nashville, TN $2,920 9% · 1 payment
  5. Colleen Kraft Infectious Disease · Atlanta, GA $1,000 3% · 1 payment

The top 5 of 18 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Family Medicine $18,039 56% · 3 practitioners
  2. Emergency Medicine $8,345 26% · 2 practitioners
  3. Neonatal-Perinatal Medicine Pediatrics $2,920 9% · 1 practitioner
  4. Anatomic Pathology & Clinical Pathology Pathology $1,084 3% · 7 practitioners
  5. Clinical Pathology/Laboratory Medicine Pathology $1,013 3% · 2 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Indiana $18,024 56% · 2 recipients
  2. California $4,373 13% · 3 recipients
  3. Massachusetts $4,000 12% · 1 recipient
  4. Tennessee $2,939 9% · 2 recipients
  5. Pennsylvania $2,000 6% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

107 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record